The concept of innovative drugs is weakening. Kexing Pharmaceuticals falls more than 10%.

Innovative drug concept fluctuated weakly in intraday trading, with China National Pharmaceutical Group falling by more than 10%. Prior to this, Haixin Shares and Tonghua Golden Horse both hit the daily limit down, while Hainan Haiyao, Dize Medicine, Hanyu Medicine, Yifang Biotechnology, and other pharmaceutical companies also posted significant declines.